Skip to main content

CITADEL ADVISORS LLC

Position in LSTA — Lisata Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in LSTA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$113,556
+$44,203 QoQ
Shares Held
22,666
-2.6% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Derivatives in LSTA

reported options exposure · as of Dec 31, 2022
CallValue
$5,692
CallShares
2,250
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. LSTA ranks #325 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LSTA

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $113,556 22,666
2024-12-31 $69,353 23,273
2023-12-31 $38,577 14,131
2023-09-30 $39,765 18,582
2023-06-30 $63,558 17,178
2022-12-31 $5,692 2,250
2022-12-31 $25,507 10,082